FLUROMILAST 500 is a medication containing Roflumilast, a phosphodiesterase-4 (PDE-4) inhibitor used in the treatment of severe chronic obstructive pulmonary disease (COPD) with symptoms of chronic bronchitis. It helps reduce inflammation in the lungs and improve breathing in patients with COPD. 

 Chronic Obstructive Pulmonary Disease (COPD): FLUROMILAST 500 is effective in managing severe COPD with symptoms of chronic bronchitis, such as persistent cough, excessive mucus production, and difficulty breathing. It helps reduce exacerbations and improve lung function. 

The recommended dose of FLUROMILAST 500 for COPD is usually 500 mcg (micrograms) once daily, taken orally with or without food. 

 Common side effects of FLUROMILAST 500 include diarrhea, nausea, headache, insomnia, and weight loss. Rare but serious side effects such as psychiatric disorders (e.g., depression, anxiety), liver problems, and allergic reactions require immediate medical attention. 

 Inform your doctor about any allergies or medical conditions before starting FLUROMILAST 500. Avoid abrupt discontinuation of the medication, as it may lead to worsening of COPD symptoms. 

 The cost of FLUROMILAST 500 can vary depending on factors such as the brand, dosage strength, and geographical location. It is available in both generic and branded forms, with generic versions often being more affordable. 

Each FLUROMILAST 500 tablet contains 500 mg of Roflumilast as the active ingredient, along with excipients and fillers to form the tablet. 

 FLUROMILAST 500, containing Roflumilast 500 mg, is a valuable medication for the treatment of severe COPD with symptoms of chronic bronchitis. It helps reduce inflammation in the lungs, improve breathing, and decrease exacerbations in COPD patients. Patients should follow the prescribed dosage and precautions, and consult their healthcare provider for personalized advice and monitoring while using FLUROMILAST 500. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.  

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com     

CALL/WHATSAPP: 7877551268, 7849827488